Skip to content

Research on the Development and Clinical Application of Composite Keratoprostheses

Research on the Development and Clinical Application of Composite Keratoprostheses

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112884
Enrollment
Unknown
Registered
2025-11-20
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end-stage cornea blindness

Interventions

Test group:Composite Keratoprosthesis Implantation

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients selected must have bilateral end-stage corneal blindness (including severe corneal vascularization due to severe eye chemical/thermal burns, complete limbal stem cell deficiency, end-stage dry eye caused by systemic autoimmune diseases (such as Stevens-Johnson syndrome, mucous membrane pemphigoid, GVHD, etc.), failure of more than two penetrating keratoplasties (with high vascularization and limbal stem cell deficiency), silicone oil-dependent corneal blindness, etc.). Other criteria include: 1. being at least 18 years old; 2. having visual potential in the surgical eye (with acceptable retinal and optic nerve structure and function); 3. no active eye infections; 4. fully understanding the indications, surgical risks, and other relevant information about artificial corneas; 5. being able to follow postoperative medication instructions and regular follow-up visits as required.

Exclusion criteria

Exclusion criteria: 1. No light perception; 2. Children, pregnant women (or those attempting pregnancy), and individuals with severe systemic diseases who cannot tolerate surgery; 3. Those who can achieve useful vision through corneal transplantation; 4. Individuals with severe mental illnesses; 5. Those with ocular conditions that severely affect visual recovery (e.g., old retinal detachment); 6. Patients and their families who do not understand the risks associated with artificial corneal surgery; 7. Those unable to adhere to medication regimens and regular follow-up reviews; 8. Individuals deemed unsuitable for participation in this clinical study by the investigator. Note: The first patient with poor preoperative visual potential, as assessed, is not excluded if the patient and their family are willing to proceed.

Design outcomes

Primary

MeasureTime frame
Morphological changes in the optic nerve and macula;Anterior segment photography;CFF;

Countries

China

Contacts

Public ContactYifei Huang

Chinese PLA General Hospital.

301yk@sina.com+86 186 0057 4957

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026